In April 2023, Sanofi’s General Medicines Unit signed a three-year Memorandum of Understanding (MoU) with the Ministry of Health of Ghana to deliver better care and improve the quality-of-life of people living with diabetes. It is estimated that over 300,000 adults in Ghana have diabetes, the majority being Type 2, while an estimated 2,500 children and adolescents (0-19 years) are living with Type 1 diabetes.
In July 2023, Sanofi and the International Diabetes Federation (IDF) signed a partnership for the training of 170 nurses and pharmacists primarily serving people living with diabetes. These nurses and pharmacists will follow training sessions enhancing core competencies to educate people with diabetes, promote healthy lifestyles and effective self-management for optimal diabetes control. One month after launch, 136 eligible nurses and pharmacists have already enrolled in the program.
The MoU also provides for the deployment of diabetes management solutions at diabetes centers in Accra, Sunyani and Tamale where 500 healthcare professionals will benefit from a targeted Mentor-Mentee medical training program. At the end of August 2023, the first cohort of the Mentor-Mentee training program launched, allowing endocrinologists to support 80 healthcare professionals in their capacity building for the treatment of people living with diabetes. The program has achieved a 90% completion rate on the first of four training modules as of the end of September.
Sanofi’s ambition is to improve and accelerate affordable and sustainable access to diabetes care for 190,000 patients in LMICs by 2025.